<DOC>
	<DOCNO>NCT00569270</DOCNO>
	<brief_summary>We detect dynamic hyperinflation ( DH ) 40 COPD ( chronic obstructive pulmonary disease ) patient moderately severe disease use metronome pace hyperventilation ( MPH ) inspiratory capacity primary end point . Hypothesis : Is tiotropium capable lung volume protect inspiratory capacity MPH induce DH v placebo randomize crossover double blind study .</brief_summary>
	<brief_title>Dynamic Hyperinflation Tiotropium</brief_title>
	<detailed_description>Study complete 29 patient study . Data analyze evaluate trough peak effect 18 µg tiotropium v placebo FEV 1 ( L ) ( force expiratory capacity one second ) , inspiratory capacity functional residual volume . In addition , study effect 18 µg tiotropium v placebo metronome pace hyperventilation induce dynamic hyperinflation . We also evaluate effect tiotropium induce increase IC ( inspiratory capacity ) v extent emphysema evaluate high resolution thin section CT lung</detailed_description>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Moderately severe COPD patient age 4085 yr post 180ug albuterol FEV 1 60 79 % predict FEV 1/FVC &lt; 70 % . Smoking history &gt; 10 pack yr. Clinically stable X 6 week . No oxygen usage . History asthma Clinically unstable Any significant medical problem preclude full cooperation study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>